Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses...
Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses...
Recent developments in the management of Cushing's syndrome
Pablo Abellán Galiana
...
Neuroendocrinology 2021 Mar 19